Blood Coagulation and Fibrinolysis, 1473-5733

Journal

More filtering options
  1. 2021
  2. 2020
  3. A rare heterozygous variant in FGB (Fibrinogen Merivale) causing hypofibrinogenemia in a Swedish family

    Marcus Fager Ferrari, Eva Leinoe, Maria Rossing, Eva Norström & Eva Zetterberg, 2020, In: Blood Coagulation and Fibrinolysis. 31, 7, p. 481-484

    Research output: Contribution to journalArticle

  4. Von Willebrand factor alloantibodies in type 3 von Willebrand disease

    Barbara Faganel Kotnik, Karin Strandberg, Maruša Debeljak, Lidija Kitanovski, Janez Jazbec, Majda Benedik-Dolničar & Alenka Trampuš Bakija, 2020, In: Blood Coagulation and Fibrinolysis. 31, 1, p. 77-79 3 p.

    Research output: Contribution to journalArticle

  5. 2016
  6. Malignancies in Swedish persons with haemophilia: a longitudinal registry study

    Susanna Lövdahl, K M Henriksson, Fariba Baghaei, Margareta Holmström, Erik Berntorp & Jan Astermark, 2016 Sep, In: Blood Coagulation and Fibrinolysis. 27, 6, p. 631–636

    Research output: Contribution to journalArticle

  7. The effect of Nordic Walking on joint status, quality of life, physical ability, exercise capacity and pain in adult persons with haemophilia

    Maryem Salim, Elisabeth Brodin, Yvonne Spaals-Abrahamsson, Erik Berntorp & Eva Zetterberg, 2016 Jun 1, In: Blood Coagulation and Fibrinolysis. 27, 4, p. 467-472 6 p.

    Research output: Contribution to journalArticle

  8. Pain and pain management in haemophilia

    Günter Auerswald, Gerry Dolan, Anne Duffy, Cedric Hermans, Victor Jiménez-Yuste, Rolf Ljung, Massimo Morfini, Thierry Lambert & Silva Zupančić Šalek, 2016, In: Blood Coagulation and Fibrinolysis. 27, 8, p. 845-854

    Research output: Contribution to journalReview article

  9. 2015
  10. Changes in bleeding patterns in von Willebrand disease after institution of long-term replacement therapy: results from the von Willebrand Disease Prophylaxis Network.

    Elena Holm, Thomas C Abshire, Joel Bowen, M A Teresa Álvarez, Paula Bolton-Maggs, Manuel Carcao, Augusto B Federici, Joan Cox Gill, Susan Halimeh, Christine Kempton, Nigel S Key, Peter Kouides, Alice Lail, Andrea Landorph, Frank Leebeek, Michael Makris, Pier Mannucci, Eveline P Mauser-Bunschoten, Diane Nugent, Leonard A Valentino & 2 others, Rochelle Winikoff & Erik Berntorp, 2015, In: Blood Coagulation and Fibrinolysis. 26, 4, p. 383-388

    Research output: Contribution to journalArticle

  11. Rationale for individualizing haemophilia care.

    Benny Sørensen, Günter Auerswald, Gary Benson, Ivo Elezović, Markus Felder, Thierry Lambert, Massimo Morfini, Eduardo Remor, Peter Salaj, Elena Santagostino, Silva Z Salek & Rolf Ljung, 2015, In: Blood Coagulation and Fibrinolysis. 26, 8, p. 849-857

    Research output: Contribution to journalReview article

  12. 2014
  13. Clotting factor level is not a good predictor of bleeding in carriers of haemophilia A and B.

    Anna Olsson, Margareta Hellgren, Erik Berntorp, Rolf Ljung & Fariba Baghaei, 2014, In: Blood Coagulation and Fibrinolysis. 25, 5, p. 471-475

    Research output: Contribution to journalArticle

  14. 2011
  15. Overcoming delayed in-vitro response to rFVIIa: effects of rFVIIa and rFVIIa analogue (vatreptacog alfa) concentration escalation in whole blood assays.

    Donald F Brophy, Erika J Martin, J Christian Barrett, Melinda E Nolte, Janice G Kuhn, Ulla Hedner & Mirella Ezban, 2011, In: Blood Coagulation and Fibrinolysis. 22, p. 541-546

    Research output: Contribution to journalArticle

  16. 2010
  17. A retrospective study of Octaplex in the treatment of bleeding in patients with haemophilia A complicated by inhibitors.

    Erik Berntorp, Sandra Figueiredo, Lucimara Futema, Katharina Pock, Sigurd Knaub, Olaf Walter, Laurenz Trawnicek & Jürgen Römisch, 2010, In: Blood Coagulation and Fibrinolysis. 21, p. 577-583

    Research output: Contribution to journalArticle

  18. 2008
  19. Sex-related differences in the associations between hyperleptinemia, insulin resistance and dysfibrinolysis

    Maria A. Eriksson, Eva Rask, Owe Johnson, Kjell Carlstrom, Bo Ahrén, Mats Eliasson, Kurt Boman & Stefan Soderberg, 2008, In: Blood Coagulation and Fibrinolysis. 19, 7, p. 625-632

    Research output: Contribution to journalArticle

  20. 2007
  21. Monitoring fondaparinux with the Sonoclot

    Caroline Nilsson & Martin Engström, 2007, In: Blood Coagulation and Fibrinolysis. 18, 7, p. 619-622

    Research output: Contribution to journalArticle

  22. 2006
  23. 2005
  24. Cost effectiveness of haemophilia treatment: a cross-national assessment.

    Barbara Lippert, Karin Berger, Erik Berntorp, Paul Giangrande, Marijke van den Berg, Wolfgang Schramm & Uwe Siebert, 2005, In: Blood Coagulation and Fibrinolysis. 16, 7, p. 477-485

    Research output: Contribution to journalArticle

  25. Long-term prophylaxis in von Willebrand disease

    Erik Berntorp & P Petrini, 2005, In: Blood Coagulation and Fibrinolysis. 16, Suppl 1, p. S23-S26

    Research output: Contribution to journalArticle

  26. Normal D-dimer concentration is a common finding in symptomatic outpatients with distal deep vein thrombosis.

    Cecilia Jennersjö, Inger Fagerberg, Sven Karlander & Tomas Lindahl, 2005, In: Blood Coagulation and Fibrinolysis. 16, 7, p. 517-523

    Research output: Contribution to journalArticle

  27. 2004
  28. Activation of fibrinolysis and coagulation in non-occlusive intestinal ischaemia in a pig model

    Stefan Acosta, Torbjorn K. Nilsson, David Bergqvist & Martin Björck, 2004, In: Blood Coagulation and Fibrinolysis. 15, 1, p. 69-76

    Research output: Contribution to journalArticle

  29. No effect of the prothrombin G20210A mutation on protein C activation in a large kindred with type I protein C deficiency.

    Carla Vossen, Karin Strandberg, Johan Stenflo, Frits Rosendaal, Peter Callas, George Long & Edwin Bovill, 2004, In: Blood Coagulation and Fibrinolysis. 15, 7, p. 573-576

    Research output: Contribution to journalArticle

  30. 2003
  31. Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study

    R Alikhan, AT Cohen, S Combe, MM Samama, L Desjardins, A Eldor, C Janbon, A Leizorovicz, Carl-Gustav Olsson & AGG Turpie, 2003, In: Blood Coagulation and Fibrinolysis. 14, 4, p. 341-346

    Research output: Contribution to journalArticle

  32. 2001
  33. 2000
  34. NovoSeven in warfarin-treated patients

    Erik Berntorp, L Stigendal, Stefan Lethagen, L Olofsson & U Hedner, 2000, In: Blood Coagulation and Fibrinolysis. 11, Suppl 1, p. S113-S115

    Research output: Contribution to journalArticle

  35. Structural model of human alpha-1-microglobulin: p

    B Villoutreix, Bo Åkerström & A Lindqvist, 2000, In: Blood Coagulation and Fibrinolysis. 11, 3, p. 261-275

    Research output: Contribution to journalArticle

  36. 1999
  37. Oubain role on erythrocyte/fibrinogen interaction

    Isabel Goncalves, Rui Mesquita, C Saldanha & J Martins e Silva, 1999, In: Blood Coagulation and Fibrinolysis. 10 , Suppl 1, p. S107

    Research output: Contribution to journalPublished meeting abstract

  38. 1994
  39. Low-molecular-weight heparin (Fragmin) versus heparin for anticoagulation during cardiopulmonary bypass in open heart surgery, using a pig model

    L Bagge, T Wahlberg, E Holmer, H Tydén, S O Nyström & T Malm, 1994 Apr, In: Blood Coagulation and Fibrinolysis. 5, 2, p. 265-72 8 p.

    Research output: Contribution to journalArticle

  40. Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin(TM)). An experimental investigation in healthy volunteers

    J. Holst, B. Lindblad, D. Bergqvist, K. Garre, H. Nielsen, U. Hedner & P. B. Ostergaard, 1994, In: Blood Coagulation and Fibrinolysis. 5, 5, p. 795-803

    Research output: Contribution to journalArticle

  41. 1993
  42. Report of a joint WHO/WFH meeting on the control of haemophilia: Carrier detection and prenatal diagnosis

    I.R. Peake, D.P. Lillicrap, V. Boulyjenkov, E. Briet, V. Chan, E.K. Ginter, E.M. Kraus, R. Ljung, P.M. Mannucci, K. Nicolaides & E.G.D. Tuddenham, 1993 Nov 25, In: Blood Coagulation and Fibrinolysis. 4, 2, p. 313-344 32 p.

    Research output: Contribution to journalArticle

  43. 1991
  44. No transplacental passage of standard heparin or an enzymatically depolymerized low molecular weight heparin

    Thomas Mätzsch, D Bergqvist, A Bergqvist, S Hodson, J Dawes, U Hedner & P Ostergaard, 1991, In: Blood Coagulation and Fibrinolysis. 2, 2, p. 273-278

    Research output: Contribution to journalArticle

  45. The influence of surgical trauma on factor XaI and IIaI activity and heparin concentration after a single dose of low-molecular-weight heparin

    Thomas Mätzsch, D Bergqvist, U S Burmark, E Holmer & K Soderberg, 1991, In: Blood Coagulation and Fibrinolysis. 2, 5, p. 651-657

    Research output: Contribution to journalArticle

  46. 1990
  47. The effect of unfractionated and low-molecular-weight heparin on the release of prostacyclin from the arterial wall

    J Brunkwall, Thomas Mätzsch & D Bergqvist, 1990, In: Blood Coagulation and Fibrinolysis. 1, 6, p. 641-645

    Research output: Contribution to journalArticle